ERYTECH Pharma S.A ERYP

ERYTECH Pharma S.A

Biotechnology

Healthcare

ERYP

21.62 M shares

NASDAQ US

traded

01 Feb 2023

listed

yes

open

1.05

52 week high

7.30

high

1.39

52 week low

1.34

low

1.05

growth

-30.30 %

previous Close

1.34

P/E ratio

-1

market cap

170 M

div yield

0

usd

Dec 2019

qoq

revenue

0.00 %

net incoming

-19.40 M

-126.27 %

eps

-1.18 %

-161.36 %

eps surprise

-27.45 %

net profit margin

-1940300000.00 %

411.00 %

operating incoming

-17.24 M

-72.47 %

net change in cash

-8.75 M

30.30 %

cash on hand

73.17 M

-45.54 %

cost of revenue

15.22 M

96.56 %